phase readout
saveNCT07469306: Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer
NOT_YET_RECRUITINGupdated 2mo ago
community read0 votes
Sponsor: Fujian Cancer Hospital. Phase: PHASE2. Conditions: Locally Advanced Rectal Cancer
view source ↗
comments(0)
5-min edit window · permanent after that